We are Sorry, This Page doesn't Exist

Puma Biotechnology Inc (NASDAQ: PBYI) shares advanced in premarket trading Wednesday on the back of an announcement concerning its breast cancer drug Nerlynx before falling after the mark read more.....»»

Puma Biotech (PBYI) files an sNDA for the nod of Nerlynx in combination with Xeloda to treat patients with HER2-positive metastatic breast cancer, having failed two or m.....»»

Puma Biotech (PBYI) out-licenses development and marketing rights to its breast cancer drug Nerlynx to Pierre Fa.....»»

Exact Sciences (EXAS) reaches a co-promotion agreement with Pfizer to commercialize its non-invasive screening test for colorectal cancer, Cologuard. The stock rallies fo.....»»

Puma Biotechnology Inc (NASDAQ: PBYI) released positive top-line results for its lead drug candidate PB272, or Nerlynx, which is being evaluated for treating HER2+ meta Latest Ratings for PBYI .....»»

Caribou Biosciences Inc. — one of the first companies to spin Nobel Prize-winning UC Berkeley professor Jennifer Doudna's CRISPR genome-editing technology out of her lab — inked a deal with drug giant AbbVie Inc. to help develop an off-the-shel.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) read more.....»»

S.....»»

Shares of Myovant Sciences soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant wi.....»»

Shares of Myovant Sciences soared 16% in premarket trade Monday, after its parent Sumitovant Biopharma said .....»»

The deal is the latest to add to Gilead's presence in cancer immunotherapy, an approach to treating cancer that harnesses the body's immune system......»»

NewLink Genetics shares jumped on Tuesday after the company announced that it entered into an exclusive worldwide license agreement with Ellipses Pharma......»»

The South San Francisco company's drug, currently in an early-phase clinical trial, targets types of breast and lung cancers as well as gastric cancer, which Asian drug makers are anxious to tackle......»»

MimiVax has long presented an exciting opportunity to develop a cutting-edge cancer therapy in Buffalo. Now the spinout from Roswell Park Comprehensive Cancer Center is a lot closer to that goal. The company – which is developing an anti-cancer .....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) Dova Pharmaceuticals.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) read more.....»»

Puma Biotechnology Inc. shares rall.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 1) read more.....»»